CCND1 and mantle cell lymphoma: [4–10] In this study, we describe the clinicopathologic features and outcome of 30 patients with CD10+ MCL and compare this cohort to a large group of MCL cases with a typical immunophenotype (CD5+, CD10-negative, CD23-negative, cyclin D1+).